Skip to main content
. 2021 Jan 22;11(2):282. doi: 10.3390/ani11020282

Table 3.

Results of publications that examined meloxicam and castration in cattle (n = 16).

Reference Method Administration Outcomes Measured Positive Administration Outcome 1
Route Dose Timing
Brown et al., 2015 [17] Surgical * PO 1.0mg/kg U Basophils and eosinophils, CBC, Hp, IFN, IL-6, monocytes, N:L, RT, TNF;
Activity; ADG, carcass characteristics 2
Hp; Activity; ADG
Laurence et al., 2018 [18] Surgical SC 0.5 mg/kg “pre-op” or “post-op” C P; Activity, baulk & chute scores; BW C P (only when given “pre-op”)
Lehmann et al., 2017 [19] Surgical SC 0.5 mg/kg 30 m PRE HR, mean arterial pressure; Somatic responses; BW HR, mean arterial pressure
Marti et al., 2018 [20] Surgical * or Band* SC 0.5 mg/kg U CBC, C H, Hp, N:L, RT, SAA, ScC, ScT; Maintenance & pain behaviors, stride length; BW, inflammation score -
Marti et al., 2019 [21] Surgical *
(+/- Branding)
SC 0.5 mg/kg IP CBC, C H, Hp, N:L, SAA, ScC, ScT; Lying/standing, pain behaviors, stride length, suckling;
ADG, healing score
-
Melendez et al., 2018 [22] Surgical * or Band* SC 0.5 mg/kg U CBC, C S, RT, SAA, ScT, SP;
Leg movement, maintenance & pain behaviors, stride length, VAS, vocalization; ADG
CBC WBC, SP; Lying time, tail flicking
Melendez et al., 2018 [23] Surgical *
(+/- Branding)
SC 0.5 mg/kg IP CBC, C S, Hp, N:L, RT, SAA, SP, ScT;
Activity, electronic reactivity measurements, leg movement, pain behaviors, stride length, VAS, vocalization; ADG
CBC WBC, N:L, ScT; Leg movement, lying time, tail flicking, walking time
Melendez et al., 2018 [24] Surgical SC 0.5 mg/kg 30 m PRE C H,S, Hp, RT, SAA, ScC, ScT, SP, WBC;
Activity, leg movement, maintenance & pain behaviors, stride length, VAS, vocalizations; ADG
C S, Hp, ScT, WBC
Musk et al., 2017 [25] Surgical SC 0.5 mg/kg 30 m PRE Fe, fibrinogen, Hp, SAA; Activity; BW -
Musk et al., 2017 [26] Surgica l SC 0.5 mg/kg 30m PRE* or “immediately after” Mechanical nociceptive threshold -
Olson et al., 2016 [27] Surgical * PO 1.0 mg/kg 2 h PRE C P, HR, substance P; Activity, pain behaviors, tail movement, VAS; Inflammation score C P, HR, substance P; Activity, VAS; Inflammation score
or Band*
Repenning et al., 2013 [28] Band * PO 1.0 mg/kg, 0.2 mg/kg, 0.5 mg/kg 24 h PRE, 0 h, 24 h POST Rectal temperature; Chute behaviors, maintenance behaviors; ADG, dry matter intake, gain:feed Rectal temperature; Bunk and standing behaviors
Roberts et al., 2015 [29] Surgical * PO 1.0 mg/kg “concurrent with procedure” CBC, C P, cytokines, glucose, Hp, leukocytes, non-esterified fatty acids, rectal temperature CBC RBC,WBC, C P, eosinophils, Hp, monocytes, neutrophils
Roberts et al., 2018 [30] Surgical * or Band * PO 15 mg/calf “concurrent with procedure” Hp; Activity; ADG, carcass characteristics Activity; ADG, back fat, ribeye area
Sutherland et al., 2019 [31] Band * PO 50mg/calf IP Respiration rate; Activity, environmental interactions, pain behaviors, rumination -
Vindevoghel et al., 2019 [32] Surgical SC 0.5 mg/kg “immediately after” Maintenance, pain and social behaviors, qualitative behavioral assessment score Qualitative behavioral assessment score

* Procedure performed without anesthesia; Variable anesthesia use between treatments; PO = per os (oral); SC = subcutaneous; U = unspecified; IP = “immediately prior”; pre- or post-op = before or after the operation/procedure; PRE = before the procedure; POST = after the procedure 1 Positive administration outcome was determined based on efficacy statements made by authors of these publications as demonstrated by a P-value less than 0.05 between meloxicam and control treatments. Outcomes Measured: ADG = average daily gain; BW = body weight; C = cortisol (HHair; PPlasma; SSalivary); CBC = complete blood count (WBCWhite blood cell count); Hp = haptoglobin; HR = heart rate; IFN = interferon gamma; IL-6 = interleukin-6; N:L = neutrophil:lymphocyte; RT = rectal temperature; SAA = serum amyloid A; SP = substance P; ScC = scrotal circumference; ScT = scrotal temperature; TNF = tumor necrosis factor; VAS = visual analog scale.